We are live on ! Find out more
CI

CX Institutional Portfolio holdings

AUM $3.46B
1-Year Est. Return 21.89%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+21.89%
3 Year Est. Return
+56.76%
5 Year Est. Return
+57.8%
10 Year Est. Return
AUM
$1.65B
AUM Growth
+$205M
Cap. Flow
+$104M
Cap. Flow %
6.33%
Top 10 Hldgs %
18.79%
Holding
594
New
139
Increased
244
Reduced
107
Closed
94

Sector Composition

Rank Sector Weight
1 Healthcare 4.81%
2 Financials 4%
3 Industrials 3.75%
4 Technology 3.64%
5 Consumer Discretionary 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVHD icon
51
Franklin US Low Volatility High Dividend Index ETF
LVHD
$633M
$7.8M 0.47%
204,927
+5,937
+3% +$220K
EWJ icon
52
iShares MSCI Japan ETF
EWJ
$21.9B
$7.64M 0.46%
140,400
+33,710
+32% +$1.77M
EWA icon
53
iShares MSCI Australia ETF
EWA
$1.35B
$7.61M 0.46%
342,550
+77,737
+29% +$1.69M
VTI icon
54
Vanguard Total Stock Market ETF
VTI
$658B
$7.1M 0.43%
37,130
-767
-2% -$148K
SHY icon
55
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$7.05M 0.43%
86,816
+4,514
+5% +$366K
EWU icon
56
iShares MSCI United Kingdom ETF
EWU
$4.05B
$6.99M 0.42%
+227,929
New +$6.68M
GVIP icon
57
Goldman Sachs Hedge Industry VIP ETF
GVIP
$556M
$6.88M 0.42%
99,135
+16,960
+21% +$1.2M
MLN icon
58
VanEck Long Muni ETF
MLN
$683M
$6.85M 0.42%
392,139
+20,828
+6% +$356K
EWW icon
59
iShares MSCI Mexico ETF
EWW
$1.9B
$6.6M 0.4%
+133,504
New +$6.72M
VOT icon
60
Vanguard Mid-Cap Growth ETF
VOT
$19.2B
$6.54M 0.4%
36,369
+4,487
+14% +$813K
BRK.B icon
61
Berkshire Hathaway Class B
BRK.B
$1.07T
$6.51M 0.4%
21,067
+2,540
+14% +$754K
ABBV icon
62
AbbVie
ABBV
$457B
$6.31M 0.38%
39,051
-20,814
-35% -$3.19M
MRK icon
63
Merck
MRK
$324B
$6.17M 0.37%
55,608
+5,553
+11% +$568K
UNH icon
64
UnitedHealth
UNH
$382B
$6.15M 0.37%
11,597
+974
+9% +$516K
VOE icon
65
Vanguard Mid-Cap Value ETF
VOE
$23.8B
$5.96M 0.36%
44,061
+10,098
+30% +$1.35M
HD icon
66
Home Depot
HD
$330B
$5.95M 0.36%
18,851
+12,315
+188% +$3.75M
LLY icon
67
Eli Lilly
LLY
$1.07T
$5.94M 0.36%
16,248
+10,183
+168% +$3.61M
DVYE icon
68
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$5.92M 0.36%
+245,482
New +$5.87M
AMGN icon
69
Amgen
AMGN
$203B
$5.92M 0.36%
22,535
+2,413
+12% +$647K
KO icon
70
Coca-Cola
KO
$352B
$5.8M 0.35%
91,216
+62,563
+218% +$3.78M
EWC icon
71
iShares MSCI Canada ETF
EWC
$6.06B
$5.79M 0.35%
177,003
+4,762
+3% +$158K
VUG icon
72
Vanguard Growth ETF
VUG
$218B
$5.79M 0.35%
163,092
+11,694
+8% +$430K
MCD icon
73
McDonald's
MCD
$189B
$5.49M 0.33%
20,818
+14,542
+232% +$3.84M
ABT icon
74
Abbott
ABT
$181B
$5.36M 0.33%
48,858
+16,222
+50% +$1.68M
SLV icon
75
iShares Silver Trust
SLV
$28.4B
$5.28M 0.32%
+239,570
New +$4.69M

Similar funds

CX Institutional's Q4 2022 Portfolio in Review

As of Q4 2022, CX Institutional held 594 positions worth $1.65B, up 14% from $1.44B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

CX Institutional deployed $104M of net new capital in Q4 2022, opening 139 new positions and adding to 244 existing holdings. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 150,015 shares worth $15M.

By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, up from 4.1% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $18M trimmed.

  • CX Institutional's largest Q4 2022 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 150,015 shares worth $15M.
  • CX Institutional added most to VanEck Intermediate Muni ETF in Q4 2022, an estimated $17M increase.
  • CX Institutional's biggest Q4 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $18M.
  • CX Institutional fully exited iShares MSCI EAFE Small-Cap ETF in Q4 2022, selling an estimated $10.1M.
  • CX Institutional's ten largest holdings make up 19% of its $1.65B portfolio in Q4 2022.
  • CX Institutional opened 139 new positions and closed 94 in Q4 2022.
  • CX Institutional's portfolio value rose 14% quarter-over-quarter to $1.65B.

Based on CX Institutional's 13F filing for Q4 2022, filed 3 Feb 2023.